Conversely, a subsequent meta-analysis conducted in 2021, which analyzed approximately 6700 patients with metastatic CRC, revealed that the frequency of KRAS mutations was statistically significantly higher in left-sided tumors [50]. Here, KRAS is linked to colorectal carcinoma.